发明名称 FUSED HETEROCYCLIC RING COMPOUND
摘要 <p>A compound represented by the following formula or a salt thereof, which has an GPR119 agonist action, is useful for the prophylaxis or treatment of diabetes, obesity and the like, and shows superior efficacy: wherein P: substituted 6-membered aromatic ring, Q: (substituted) 6-membered aromatic ring, A 1 : CR 4a R 4b , NR 4c , O, S, SO or SO 2 {R 4a-4c : H etc.}, L 1 : (substituted) C 1-5 alkylene, L 2 : a bond or (substituted) C 1-3 alkylene, L 3-4 : (substituted) C 1-3 alkylene, R 1 : H, X, CN, (substituted) hydrocarbon, (substituted) heterocycle or (substituted) OH, or (substituted) 4- to 8-membered (heterocyclic) ring together with A 1 , R 2 : H, CN, (substituted) hydrocarbon, and R 3a : -COSR A1 , (substituted) 5- or 6-membered aromatic ring {R A1 : (substituted) hydrocarbon or (substituted) heterocycle}.</p>
申请公布号 EP2399914(A4) 申请公布日期 2012.08.29
申请号 EP20100743789 申请日期 2010.02.17
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 RIKIMARU, KENTARO;IMOTO, HIROSHI;KAMAURA, MASAHIRO
分类号 C07D401/14;A61K31/454;A61K31/506;A61K31/519;A61K31/5377;A61K31/55;A61P1/00;A61P1/02;A61P1/04;A61P1/08;A61P1/12;A61P1/16;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P7/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12 主分类号 C07D401/14
代理机构 代理人
主权项
地址